Objective. We examined the prevalence of nephropathy in unselected patients with rheumatoid arthritis (RA) by measurement of marker proteins for glomerular and tubular damage in urine.
Rheumatoid arthritis (RA) is a systemic disease which complication of RA may also lead to renal failure [4, 5] . Whether rheumatoid glomerulonephritis in RA repmainly affects the joints, but which can also lead to extra-articular organ manifestations. Renal involvement resents a separate disease entity is still a matter of controversy [6 ] . Recent reports describe RA patients is not uncommon, but impairment of renal function is generally mild; end-stage renal failure is believed to be who took neither gold nor penicillamine but still developed a (usually mesangioproliferative) glomerulorare. Nevertheless, in most studies, patients with RA do have a high mortality rate, which has been attributed to nephritis [7, 8] . The incidence of nephropathy in patients with RA is renal failure caused by amyloidosis and chronic nephritis [1] . not known, although RA patients frequently show subclinical renal dysfunction [9, 10] . Serum creatinine and It is difficult to determine whether a nephropathy in RA patients is caused by the underlying disease and its creatinine clearance have been shown to lack the sensitivity to detect renal dysfunction in RA [11] . Proteinuria complications or by nephrotoxic medication. Any therapy involving disease-modifying anti-rheumatic was shown to be more sensitive for the detection of renal damage in RA compared to measurement of serum drugs (DMARDs; gold or penicillamine) may cause a membranous glomerulopathy [2] , which in turn can creatinine [12] . For detecting mild proteinuria, single protein measurement is more sensitive than sodium induce pathological proteinuria. Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) can evoke dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE; [13, 14] ), the standard method for differan interstitial nephritis, while analgesic mixtures may lead to analgesic nephropathy [3] . Systemic amyloidosis entiating different types of proteinuria. It is, therefore, important that more sensitive tests are evaluated for is the most frequent cause of nephrotic proteinuria and renal failure in RA patients. Rheumatoid vasculitis as a identifying early stages of renal damage. The pattern of proteinuria allows localization within the nephron of the causative damage [13] . Increased Submitted 12 February 1998 (M r 150 kDa) in urine indicates more severe glomerular damage. The urinary concentration of Alb, and possibly differences existed between the two groups regarding age, amount of gold medication, and the incidence of of IgG, allows the differentiation of selective and unselective glomerular proteinuria. a1-Microglobulin rheumatoid vasculitis ( Table 1) . Retrospective analysis of medical records of all patients was performed without (a1-MG) (M r 33 kDa) passes the glomerular membrane and appears in the urine if its tubular reabsorption is knowledge of the urinary results. No renal biopsies were performed, amyloidosis and diminished since it is not degraded in urine [14] . Hence, an isolated elevated urinary concentration of a1-MG is vasculitis were proven histologically by biopsy of extrarenal organs. Since gold and penicillamine are a marker of tubular damage. Mixed glomerular and tubular proteinuria indicates complex and usually more considered to be nephrotoxic, current as well as former consumption of these drugs was documented. No advanced renal damage.
The aim of our study was to evaluate the prevalence NSAIDs were prescribed to RA patients and the control group in hospital. All patients reported regular conof nephropathy in RA patients by applying a highly sensitive immunoluminometric assay (ILMA; [14] ) for sumption of NSAIDs for several years, as prescribed by their general practitioner; no differences in the amount the quantification of individual urinary marker proteins excreted in the event of glomerular or tubular damage or duration of consumption of NSAIDs could be revealed. Accompanying illnesses that might cause proand to specify the possible causative agents of renal damage.
teinuria were recorded.
Methods

Patients and methods
Proteinuria. Twenty-four hour urine was collected, a sample was drawn, and the proteins were measured by Patients a semi-automatic luminometer. The quotient between Forty-four non-selected, consecutive hospital patients the protein concentration (mg/l ) and urinary creatinine (treated as in-patients) with RA (32 women, 12 men, concentration (g/l ) was calculated (mg protein/g urinary median age 61 yr, range 31-84 yr) were enrolled in the creatinine) to elicit differences in urine concentrations study ( Table 1 ). All RA patients fulfilled the revised due to differences in renal function and hydration of criteria of the American College of Rheumatology patients. The evaluation was based on the normal values (ACR) classification [15] . Patients with proven amylestablished by Hofmann and Guder [18] . oidosis were excluded. The control group consisted of Immunoluminometric assay. Urinary protein excretion 46 non-selected hospital patients with generalized was measured by a highly sensitive ILMA, which is a osteoarthritis (OA) (28 women, 18 men, median age sandwich method using an immobilized antibody and a 49 yr, range 36-75 yr). Patients were diagnosed to have second labelled antibody [14] . Urinary concentrations OA according to ACR criteria of OA [16, 17] after RA of Alb, IgG and a1-MG were measured (detection limits: or other underlying diseases were excluded. Significant Alb 0.21 mg/l; IgG 0.2 mg/l; a1-MG 0.03 mg/l ). Typing of the proteinuria followed the system of Boesken [12] for classifying SDS-PAGE patterns of urinary proteins T 1. Characteristics of patients with rheumatoid arthritis (RA ( Table 2) . <20; a1-MG < 14 Type III Highly selective glomerular Alb > 25; IgG < 10; therapy, months) Gold and 1 0 NS PU a1-MG < 14 Type IV Tubular PU Alb < 25; a1-MG > 14 penicillamine (n) (median duration of (88) Type V Mixed PU Alb > 25; IgG > 10; a1-MG > 14 therapy, months)
Units of proteins are urinary protein (mg)/urinary creatinine (g). NSAIDs, non-steroidal anti-inflammatory drugs; ACE, angiotensinconverting enzyme. NS, P > 0.05. Medians (range).
Alb, albumin; IgG, immunoglobulin G; a1-MG, a1-microglobulin.
ment, were documented. Blood and urine samples were significant difference in inflammatory markers as compared with the control group (CRP: 10.0 vs <5 mg/l, always collected on the same day. Normal values for creatinine were determined by hospital laboratory refer-P = 0.12; ESR: 22 vs 23 mm/1 h, P = 0.81). Impaired renal function, as detected by elevated serum ence values, creatinine clearance data were taken from Kampmann et al. [19] .
creatinine or reduced creatinine clearance, was detected in two RA patients. The median serum creatinine in all Statistical analysis was performed by Wilcoxon matched pairs test, data were not normally distributed.
patients with RA (0.87 mg/dl ) did not differ significantly from that of the control group (P = 0.1), but their Groups of patients were analysed by calculation of medians.
creatinine clearance was reduced (80.0 ml/min; P = 0.038). Since the RA patients were older, correction of creatinine clearance for age (expected normal loss of Results clearance: 0.75 ml/min/yr lifetime [20] ) left no difference between RA patients and the control group. All 46 patients of the OA control group had normal excretory renal function as corrected for age and gender
The patients with RA showed a broad range of urinary protein excretion: Alb and IgG excretion, which (medians: creatinine 0.91 mg/dl; creatinine clearance 86 ml/min) ( Table 3) . Their medians for proteinuria is indicative of glomerular damage, ranged from 2.6 to 14 222 mg/g and 0.28 to 1 681 mg/g urinary creatinine, were also in the normal range (Alb 4.4; IgG 1.4; a1-MG 6.2 mg/g urinary creatinine) ( Table 4 ). Seven of the 46 respectively. The tubular marker protein a1-MG ranged from 0.9 to 453 mg/g urinary creatinine. Qualitative (15%) OA patients were found to have a pathological proteinuria, which was very mild in all cases (Alb analysis of the proteinuria disclosed 20 patients without pathological proteinuria (type 0), three patients with maximum 73, a1-MG maximum 42.2 mg/g urinary creatinine). In 6/7 patients, a possible cause for the mild highly selective glomerular (type III ), 10 with tubular (type IV ) and 10 with non-selective tubular-glomerular proteinuria could be identified: diabetes mellitus, hypertension or nephrotoxic co-medication.
(type V ) proteinuria. In six of 24 of patients with pathological proteinuria Twenty-four of the 44 RA patients (55%) exhibited a pathological proteinuria (all RA patients: Alb 6.7; (25%), a possible cause for the proteinuria was found: rheumatic vasculitis or consumption of gold or penicillaa1-MG 12.7 mg/g urinary creatinine; for both P < 0.001 vs control group; Table 4), even though there was no mine. All of these patients had a non-selective tubular- glomerular proteinuria (type V ) ( Table 4) . Nine of the severe renal damage has occurred [11] . In the control group of OA patients, only 7/47 patients had pro-44 RA patients (20%) had a history of nephrotoxic DMARD, two of whom showed pathological proteinuria, which was very mild and in most cases explainable by other diseases. The significantly lower age of teinuria. Those patients taking gold or penicillamine had a proteinuria below the nephrotic range (medians: the OA patients does not account for their lower incidence of proteinuria, since aging alone does not induce Alb 678; a1-MG 70.9 mg/g urinary creatinine), although the creatinine clearance was equal to that of the control proteinuria [21] . Earlier reports of proteinuria as a marker of renal group (median 86 ml/min). In addition, a pathological mixed glomerular-tubular proteinuria (type V ) was damage in RA emphasized its sensitivity compared to measurement of serum creatinine [12] . However, albudetected in four of the five patients with rheumatic vasculitis (medians: Alb 367; a1-MG 181 mg/g urinary stix, a method often used to measure albumin excretion, was shown not to be as sensitive at detecting renal creatinine). These patients also showed a decreased creatinine clearance (65 ml/min).
damage [12] as multifractional electrophoresis of urinary proteins, a method even less sensitive than the ILMA No causative agent for the proteinuria could be identified in 18 of the 24 RA patients with pathological used here. Other studies are attenuated by methodical problems, e.g. concentration of urine was not taken into proteinuria (75%) ( Table 4) . Three patients had a highly selective glomerular (type III ) proteinuria (median: Alb account [22] , markers of glomerular damage were not measured [9] , tubular markers or the methods applied 39.1 mg/g urinary creatinine), 10 patients a tubular (type IV ) proteinuria (median: a1-MG 23.1 mg/g urinhad inadequate sensitivity [22] . Our findings on glomerular damage are comparable to the results of Pedersen ary creatinine) and five a non-selective tubular-glomerular (type V ) proteinuria (medians: Alb 503; a1-MG et al. [10] , who looked carefully for albuminuria (defined as Alb excretion in relation to urinary creatinine concen-83.2 mg/g urinary creatinine). Renal function did not differ significantly between the proteinuria type III and tration): he detected pathological albuminuria in 27.7% of patients, a figure comparable to the 32% (14/44) of type IV groups and the control group (medians: creatinine 0.8 and 0.84 mg/dl; clearance 80 and 67 ml/min).
RA patients in our study. Albustix and other methods used to measure Alb excretion focus on glomerular Patients with type V proteinuria had a worse renal function than the control group (medians: creatinine damage, since Alb is a marker protein of glomerular injury [13] . Ten of our 28 (37%) patients with proteinuria 1.40 mg/dl, creatinine clearance 65 ml/min), although the differences were not statistically significant (P = 0.22 had isolated tubular proteinuria, which would have been overlooked by measurement of Alb alone. and 0.23).
The duration of disease did not differ significantly Glomerular proteinuria without any evidence of a causative agent was detected in 8/44 RA patients (18%). between patients with and without proteinuria (medians: 2.8 vs 5.6 yr; P = 0.33). Patients who took nephrotoxic A high prevalence of microalbuminuria of unknown origin and glomerulopathy without associated drug DMARDs (gold; penicillamine) had a longer history of RA (median 11.6 yr) than those who did not (median therapy in patients with RA has already been described [7, 8, 10] . The proteinuria was in the subnephrotic range 2.53 yr), although the difference was not statistically significant (P = 0.08).
in most of our patients. Possible reasons for the glomerular proteinuria in our patients include minor amyloid deposits, glomerulonephritis or unspecific glomerular Discussion changes (e.g. due to hypertension). It is conceivable that minor glomerular proteinuria in RA is caused by small We have looked for glomerular and tubular renal damage in unselected in-patients with RA by sensitive glomerular amyloid deposits, but no data exist on a 'minor' form of amyloidosis in RA. Besides various methods. We used an ILMA to determine urinary protein excretion as an indicator of glomerular and tubular forms of glomerulonephritis (proliferative [23] , necrotizing [5] ) detected in RA, in 28% of renal biopsies specific damage. A high proportion of our RA patients (55%) showed pathological proteinuria as a symptom of glomerular changes were described. These biopsies show a mild hypercellularity with deposits of immunonephropathy; tubular proteinuria especially was detected in unexpectedly many cases (36% type IV or V proglobulins and complement, termed variously 'mild mesangial glomerulopathy', 'mesangial glomerulonephritis' teinuria). Although many of the hospital patients examined had secondary complications of RA (e.g. vasculitis; [24] and, in earlier studies, 'rheumatoid glomerulonephritis'. It can be assumed that such glomerular Table 1 ), in most patients (75%; Table 3) no possible cause for the proteinuria was identified.
changes are the underlying renal disease in at least some of our eight patients. In only two of the 48 RA patients was serum creatinine elevated and creatinine clearance reduced. All patients
The incidence of glomerulonephritis in RA is not known, but the available data suggest a higher incidence with reduced creatinine clearance had proteinuria. This confirms that serum creatinine and creatinine clearance than in the general population [25] . In previous studies, many cases of glomerulonephritis were attributed to are not sensitive indicators for early stages of renal damage in RA. Since the muscle mass and therefore drug therapy [26 ] . It now appears that glomerular injury as a complication of nephrotoxic medication was overcreatinine production are diminished in patients with RA, serum creatinine may not reflect renal changes until emphasized in the past. Only five of our 18 patients with glomerular or mixed proteinuria had a history of consideration in most studies on renal disease in RA, relying instead on renal biopsies [23, 26 ] The majority of our patients with a nephropathy of needed, since renal disease is a major problem in this disorder: renal-related deaths probably make a signifiunknown aetiology (10/18; 56%) had isolated tubular proteinuria. Tubulointerstitial damage was not regarded cant contribution to increased mortality in RA [1] . However, the contribution of renal disease to the as a specific complication of RA in former publications. Although it was described in 14% of autopsies, it was increased mortality in RA is still under discussion, since former studies described no excess fatalities attributable regarded as unspecific [4] . In biopsy studies on 140 RA patients with evidence of renal disease, only four cases to renal disease [33] or a death rate 20 times that of control population [32] . Nephropathy in RA should be of 'tubulointerstitial disease' and one of acute interstitial nephritis were described [23, 26 ] . This probably underdefined as a clinical entity, since reduced renal function in RA can be caused by different renal changes such as estimates the role of the tubulointerstitium for renal function since clinicopathological studies have shown amyloidosis, drug-induced damage or imprecisely defined conditions such as 'rheumatoid glomerulothat the integrity of the interstitium is more important for determination of the glomerular filtration rate than nephritis'. The precise renal diagnosis in a single patient, especially with end-stage renal failure, is difficult to glomerular obliteration [27] . Proteinuria of tubular origin was detected using the less sensitive SDS-PAGE determine, it is more important to identify clinical risk factors for progressive renal disease. In Pima Indians in 14% of 80 patients with RA, and an even higher percentage of patients excreted enzymes, indicating with RA, proteinuria was the highest risk factor for excess mortality [34] besides age and male gender, tubular damage [28]. Boers et al. [9] described the excretion of tubular enzymes in 15/35 patients with RA.
although the contribution of diabetes in this group is a matter of discussion. We propose that nephropathy Taken together, these data underscore the necessity of using markers of tubular injury in addition to glomerular should be assumed in RA patients with significantly reduced creatinine clearance (as corrected for age and markers such as Alb.
The reason for the high prevalence of tubular damage gender), or increased urinary excretion of glomerular (e.g. Alb) or tubular markers (a1-MG, several other in RA is not known. It might be due to the induction of an interstitial nephritis by medication with NSAIDs.
marker proteins exist), as measured by sensitive methods. An interfering cause of renal damage (urinary This seems unlikely, however, since tubular proteinuria was absent in our control group of OA patients, tract infection; diabetes; current nephrotoxic medication) should be excluded. although NSAIDs and probably other analgesics were taken equally by both groups. Moreover, earlier reports
The lack of data on the progression of renal disease from microproteinuria to renal disease as a cause of [29] showed that RA patients only rarely develop an analgesic nephropathy, although they regularly take death in RA represents a dire gap in our knowledge about nephropathy in RA. A linear loss of renal function analgesics. This low incidence can be explained by rigorous controls, low doses and the avoidance of comonce impaired renal function has emerged has been demonstrated in various renal diseases [35] . In patients bination preparations.
Four of our five patients with rheumatoid vasculitis, with diabetes mellitus, a relatively linear loss of renal function following the emergence of proteinuria has proven histologically by biopsy of extrarenal organs, had a nephropathy in terms of a non-selective tubularbeen described [36 ] , with only the downward slope differing interindividually. As long as no longitudinal glomerular proteinuria (type V ), an extremely high proportion compared to that reported in previous pubstudies on proteinuria in RA are available, it appears reasonable to expect a loss of renal function following lications [30] . In a recent study, a necrotizing glomerulonephritis was documented in 10/112 renal biopsies of evidence of proteinuria in patients with RA. Future studies should focus on renal pathology and the progpatients with RA and evidence of renal disease [5] . Nine of these patients had impaired renal function (median nosis associated with early stages of renal damage in RA. creatinine 726 mmol/l ), eight experienced marked improvement of renal function after therapy. Our data
